Vimarsana
Biggest News Aggregation in the World

Peter Slover News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Slover. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Slover Today - Breaking & Trending Today

Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary - Vimarsana News

Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary

SAN DIEGO--(BUSINESS WIRE)--Jun 3, 2024--

Contineum Therapeutics Announces Pricing of Initial Public - Vimarsana News

Contineum Therapeutics Announces Pricing of Initial Public

SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Contineum Therapeutics, Inc. (Contineum), a clinical stage biopharmaceutical company focused on discovering...

Contineum Therapeutics Announces Pricing of Initial Public Offering - Vimarsana News

Contineum Therapeutics Announces Pricing of Initial Public Offering

SAN DIEGO, April 04, 2024 -- Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target...

Pipeline Therapeutics to Participate in Multiple Upcoming Investor Conferences - Vimarsana News

Pipeline Therapeutics to Participate in Multiple Upcoming Investor Conferences

SAN DIEGO--(BUSINESS WIRE)--Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today participation in the following upcoming investor conferences:Morgan Stanley 21st Annual Global Healthcare Conference, September 11-13, 2023, NY, NY:Pipeline management...

Pipeline Therapeutics Announces Global License and Development Agreement for Investigational Neuroscience Therapy, PIPE-307 - Vimarsana News

Pipeline Therapeutics Announces Global License and Development Agreement for Investigational Neuroscience Therapy, PIPE-307

SAN DIEGO - Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that it has entered into a global license and development... | April 18, 2023